Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 452 206
Medical Information e-mail: medicalinformationuk@merck.com
Patient Information Leaflet last updated on the eMC: 28/01/2009
PIL Maxalt Melt 10 mg oral lyophilisates

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/01/2009 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 11/11/2008 and displayed until 28/01/2009
Reasons for adding or updating:
  • Change to storage instructions
  • Change to side-effects
  • Change of contra-indications
  • Change to Further Information section
  • Change to warnings or special precautions for use
Updated on 09/05/2008 and displayed until 11/11/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 14/04/2008 and displayed until 09/05/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
  • Change to drug interactions
Updated on 20/01/2004 and displayed until 14/04/2008
Reasons for adding or updating:
  • Update to PIL
Updated on 26/02/2002 and displayed until 20/01/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 30/07/2001 and displayed until 26/02/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 09/08/2000 and displayed until 30/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   rizatriptan


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk